Pitfalls in the diagnosis of brain tumours

AMP Omuro, CC Leite, K Mokhtari… - The Lancet …, 2006 - thelancet.com
Establishing the diagnosis of a brain tumour is not always a straightforward process. Many
non-neoplastic neurological diseases can mimic brain neoplasms on neuroimaging or on …

Lessons learned in the development of targeted therapy for malignant gliomas

AMP Omuro, S Faivre, E Raymond - Molecular cancer therapeutics, 2007 - AACR
… A few direct genetic abnormalities have also been identified, such as PDGFR-α amplification
and a constitutive activating mutation consisting of a deletion in exons 8 and 9. In situ …

[HTML][HTML] Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report

…, MC Chamberlain, JY Blay, AJM Ferreri, AMP Omuro… - Annals of oncology, 2007 - Elsevier
Background: Primary intraocular lymphoma (PIOL) is an uncommon subset of primary central
nervous system lymphoma. Because it is rare and difficult to diagnose, the natural history …

Delayed neurotoxicity in primary central nervous system lymphoma

AMP Omuro, LS Ben-Porat, KS Panageas… - Archives of …, 2005 - jamanetwork.com
Background Treatment for primary central nervous lymphoma (PCNSL) with chemotherapy
and radiotherapy has resulted in improved survival, but some patients develop neurologic …

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

AMP Omuro, MG Kris, VA Miller… - … Journal of the …, 2005 - Wiley Online Library
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall
cell lung carcinoma after response to gefitinib - Omuro - 2005 - Cancer - Wiley Online …

Primary CNS lymphoma with intraocular involvement: international PCNSL collaborative group report

SA Grimm, CA McCannel, AMP Omuro, AJM Ferreri… - Neurology, 2008 - AAN Enterprises
Objective: To describe the demographics, diagnostic details, therapeutic management, and
outcome in patients with primary CNS lymphoma (PCNSL) with ocular involvement. Methods…

Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma

…, JJ Graber, Z Zhang, W Shi, AI Holodny, AMP Omuro - Neurology, 2011 - AAN Enterprises
Objective: To examine the potential utility of conventional MRI signs in differentiating
pseudoprogression (PsP) from early progression (EP). Methods: This retrospective study reviewed …

Ventriculoperitoneal shunt in patients with leptomeningeal metastasis

AMP Omuro, EC Lallana, MH Bilsky, LM DeAngelis - Neurology, 2005 - AAN Enterprises
… The remaining third of CSF obstruction is seen in the intracranial compartment and may
occur at several locations in addition to intraventricular as reported by Omuro. CSF …

Pretreatment dynamic susceptibility contrast MRI perfusion in glioblastoma: prediction of EGFR gene amplification

…, JJ Graber, W Shi, Z Zhang, J Huse, AMP Omuro - Clinical …, 2015 - Springer
Background and Purpose Molecular and genetic testing is becoming increasingly relevant
in GBM. We sought to determine whether dynamic susceptibility contrast (DSC) magnetic …

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

AMP Omuro, L Taillandier, O Chinot, C Carnin… - Journal of neuro …, 2007 - Springer
Background Treatment for primary CNS lymphoma (PCNSL) in the elderly is associated
with lower response rates and higher risks of acute and late delayed toxicity as compared to …